A genome-wide association study follow-up suggests a possible role for PPARG in systemic sclerosis susceptibility

Arthritis Research and Therapy

Volumn 16, Issue 1, 2014, Pages

  López Isac, Elena ^a   Bossini Castillo, Lara ^a   Simeon, Carmen P ^b   Egurbide, María V ^c   Alegre Sancho, Juan J ^d   Callejas, Jose L ^e   Roman Ivorra, José A ^f   Freire, Mayka ^g   Beretta, Lorenzo ^h   Santaniello, Alessandro ^h   Airó, Paolo ⁱ   Lunardi, Claudio ^j   Hunzelmann, Nicolas ^k   Riemekasten, Gabriela ^l   Witte, Torsten ^m   Kreuter, Alexander ⁿ   Distler, Jörg H W ^o   Schuerwegh, Annemie J ^p   Vonk, Madelon C ^q   Voskuyl, Alexandre E ^r   Shiels, Paul G ^s   van Laar, Jacob M ^t   Fonseca, Carmen ^u   Denton, Christopher ^u   Herrick, Ariane ^v   Worthington, Jane ^v   Assassi, Shervin ^w   Koeleman, Bobby P ^x   Mayes, Maureen D ^w   Radstake, Timothy R D J ^x   Martin, Javier ^a   Ortego Centeno, Norberto ^e   Ríos, Raquel ^e   Navarrete, Nuria ^y   Portales, Rosa García ^z   Camps, María Teresa ^aa   Fernández Nebro, Antonio ^aa   González Escribano, María F ^ab   Sánchez Román, Julio ^ab   García Hernández, Francisco José ^ab   Castillo, Ma Jesús ^ab   Aguirre, Ma Ángeles ^ac   Gómez Gracia, Inmaculada ^ac   Carreira, Patricia ^ad   Fernández Gutiérrez, Benjamín ^ae   Rodríguez Rodríguez, Luis ^ae   Vicente, Esther ^af   Andreu, José Luis ^ag   de Castro, Mónica Fernández ^ag   de la Peña, Paloma García ^ah   López Longo, Francisco Javier ^ai   Martinez, Lina ^ai   Fonollosa, Vicente ^b   Simeón, Carmen Pilar ^b   Espinosa, Gerard ^aj   Castellví, Ivá ^ak   Tolosa, Carlos ^al   Pros, Anna ^am   Carballeira, Mónica Rodríguez ^an   Narváez, Francisco Javier ^an   Rivas, Manel Rubio ^an   Santamarí, Vera Ortiz ^ao   González Gay, Miguel Ángel ^ap   Díaz, Bernardino ^aq   Trapiella, Luis ^aq   Sousa, Adrián ^g   Mateo, Patricia Fanlo ^ar   Sáez Comet, Luis ^as   Díaz, Federico ^at   Hernández, Vanesa ^at   Beltrán, Emma ^au   Blanco García, Francisco J ^av   Oreiro, Natividad ^av   more..

^a INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c HOSPITAL DE CRUCES   (Spain)

^d Hospital del Doctor Peset Aleixandre   (Spain)

^e HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^f HOSPITAL UNIVERSITARIO LA FE   (Spain)

^g UNIVERSITY HOSPITAL COMPLEX OF VIGO   (Spain)

^h FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

ⁱ Spedali Civili   (Italy)

^j UNIVERSITY OF VERONA   (Italy)

^k UNIVERSITY OF COLOGNE   (Germany)

^l CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^m HANNOVER MEDICAL SCHOOL   (Germany)

ⁿ RUHR UNIVERSITY BOCHUM   (Germany)

^o UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^p LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^q RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^r VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^s UNIVERSITY OF GLASGOW   (United Kingdom)

^t NEWCASTLE UNIVERSITY   (United Kingdom)

^u ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^v UNIVERSITY OF MANCHESTER   (United Kingdom)

^w UNIVERSITY OF TEXAS   (United States)

^x UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^y HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^z HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^aa HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^ab HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^ac HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^ad HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^ae HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^af HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^ag HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^ah Hospital Madrid Norte Sanchinarro   (Spain)

^ai HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^aj HOSPITAL CLÍNIC   (Spain)

^ak HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^al HOSPITAL DE SABADELL   (Spain)

^am HOSPITAL DEL MAR   (Spain)

^an HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^ao HOSPITAL GENERAL DE GRANOLLERS   (Spain)

^ap HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^aq HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^ar Instituto de Investigación Sanitaria de Navarra   (Spain)

^as HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^at HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^au HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

^av UNIVERSITY OF A CORUÑA   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CHRNA9 PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FOLLOW UP; GENE LOCUS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC SCLEROSIS; ADULT; FEMALE; GENETIC PREDISPOSITION; GENETICS; MALE; META ANALYSIS; MIDDLE AGED;

ADULT; COHORT STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PPAR GAMMA; SCLERODERMA, SYSTEMIC;

EID: 84892166010     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4432     Document Type: Article

References (30)

1. Gabrielli A, Avvedimento EV, Krieg T. Scleroderma. N Engl J Med 2009, 360:1989-2003. 10.1056/NEJMra0806188, 19420368.
2. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA, Rowell N, Wollheim F. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988, 15:202-205.
3. Martin JE, Bossini-Castillo L, Martin J. Unraveling the genetic component of systemic sclerosis. Hum Genet 2012, 131:1023-1037. 10.1007/s00439-011-1137-z, 22218928.
4. Assassi S, Radstake TR, Mayes MD, Martin J. Genetics of scleroderma: implications for personalized medicine?. BMC Med 2013, 11:9. 10.1186/1741-7015-11-9, 3568008, 23311619.
5. Radstake TR, Gorlova O, Rueda B, Martin JE, Alizadeh BZ, Palomino-Morales R, Coenen MJ, Vonk MC, Voskuyl AE, Schuerwegh AJ, Broen JC, Van Riel PL, Van't Slot R, Italiaander A, Ophoff RA, Riemekasten G, Hunzelmann N, Simeon CP, Ortego-Centeno N, Gonzalez-Gay MA, Gonzalez-Escribano MF, Airo P, Van Laar J, Herrick A, Worthington J, Hesselstrand R, Smith V, De Keyser F, Houssiau F, Chee MM, et al. Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus. Nat Genet 2010, 42:426-429. 10.1038/ng.565, 2861917, 20383147.
6. Allanore Y, Saad M, Dieude P, Avouac J, Distler JH, Amouyel P, Matucci-Cerinic M, Riemekasten G, Airo P, Melchers I, Hachulla E, Cusi D, Wichmann HE, Wipff J, Lambert JC, Hunzelmann N, Tiev K, Caramaschi P, Diot E, Kowal-Bielecka O, Valentini G, Mouthon L, Czirjak L, Damjanov N, Salvi E, Conti C, Muller M, Muller-Ladner U, Riccieri V, Ruiz B, et al. Genome-wide scan identifies TNIP1, PSORS1C1, and RHOB as novel risk loci for systemic sclerosis. PLoS Genet 2011, 7:e1002091. 10.1371/journal.pgen.1002091, 3131285, 21750679.
7. Gorlova O, Martin JE, Rueda B, Koeleman BP, Ying J, Teruel M, Diaz-Gallo LM, Broen JC, Vonk MC, Simeon CP, Alizadeh BZ, Coenen MJ, Voskuyl AE, Schuerwegh AJ, Van Riel PL, Vanthuyne M, Van't Slot R, Italiaander A, Ophoff RA, Hunzelmann N, Fonollosa V, Ortego-Centeno N, Gonzalez-Gay MA, Garcia-Hernandez FJ, Gonzalez-Escribano MF, Airo P, Van Laar J, Worthington J, Hesselstrand R, Smith V, et al. Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy. PLoS Genet 2011, 7:e1002178. 10.1371/journal.pgen.1002178, 3136437, 21779181.
8. Bossini-Castillo L, Martin JE, Broen J, Gorlova O, Simeon CP, Beretta L, Vonk MC, Callejas JL, Castellvi I, Carreira P, Garcia-Hernandez FJ, Fernandez Castro M, Coenen MJ, Riemekasten G, Witte T, Hunzelmann N, Kreuter A, Distler JH, Koeleman BP, Voskuyl AE, Schuerwegh AJ, Palm O, Hesselstrand R, Nordin A, Airo P, Lunardi C, Scorza R, Shiels P, van Laar JM, Herrick A, et al. A GWAS follow-up study reveals the association of the IL12RB2 gene with systemic sclerosis in Caucasian populations. Hum Mol Genet 2012, 21:926-933. 10.1093/hmg/ddr522, 3298110, 22076442.
9. Martin JE, Broen JC, Carmona FD, Teruel M, Simeon CP, Vonk MC, Van't Slot R, Rodriguez-Rodriguez L, Vicente E, Fonollosa V, Ortego-Centeno N, Gonzalez-Gay MA, Garcia-Hernandez FJ, De la Pena PG, Carreira P, Voskuyl AE, Schuerwegh AJ, van Riel PL, Kreuter A, Witte T, Riemekasten G, Airo P, Scorza R, Lunardi C, Hunzelmann N, Distler JH, Beretta L, van Laar J, Chee MM, Worthington J, et al. Identification of CSK as a systemic sclerosis genetic risk factor through Genome Wide Association Study follow-up. Hum Mol Genet 2012, 21:2825-2835. 10.1093/hmg/dds099, 3368627, 22407130.
10. Sharif R, Mayes MD, Tan FK, Gorlova OY, Hummers LK, Shah AA, Furst DE, Khanna D, Martin J, Bossini-Castillo L, Gonzalez EB, Ying J, Draeger HT, Agarwal SK, Reveille JD, Arnett FC, Wigley FM, Assassi S. IRF5 polymorphism predicts prognosis in patients with systemic sclerosis. Ann Rheum Dis 2012, 71:1197-1202. 10.1136/annrheumdis-2011-200901, 3375372, 22440820.
11. Franke A, McGovern DP, Barrett JC, Wang K, Radford-Smith GL, Ahmad T, Lees CW, Balschun T, Lee J, Roberts R, Anderson CA, Bis JC, Bumpstead S, Ellinghaus D, Festen EM, Georges M, Green T, Haritunians T, Jostins L, Latiano A, Mathew CG, Montgomery GW, Prescott NJ, Raychaudhuri S, Rotter JI, Schumm P, Sharma Y, Simms LA, Taylor KD, Whiteman D, et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet 2010, 42:1118-1125. 10.1038/ng.717, 3299551, 21102463.
12. Anderson CA, Boucher G, Lees CW, Franke A, D'Amato M, Taylor KD, Lee JC, Goyette P, Imielinski M, Latiano A, Lagace C, Scott R, Amininejad L, Bumpstead S, Baidoo L, Baldassano RN, Barclay M, Bayless TM, Brand S, Buning C, Colombel JF, Denson LA, De Vos M, Dubinsky M, Edwards C, Ellinghaus D, Fehrmann RS, Floyd JA, Florin T, Franchimont D, et al. Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet 2011, 43:246-252. 10.1038/ng.764, 3084597, 21297633.
13. Sestak AL, Furnrohr BG, Harley JB, Merrill JT, Namjou B. The genetics of systemic lupus erythematosus and implications for targeted therapy. Ann Rheum Dis 2011, 70:i37-i43. 10.1136/ard.2010.138057, 21339217.
14. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007, 81:559-575. 10.1086/519795, 1950838, 17701901.
15. Skol AD, Scott LJ, Abecasis GR, Boehnke M. Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet 2006, 38:209-213. 10.1038/ng1706, 16415888.
16. Ioannidis JP, Thomas G, Daly MJ. Validating, augmenting and refining genome-wide association signals. Nat Rev Genet 2009, 10:318-329. 10.1038/nrg2544, 19373277.
17. Bossini-Castillo L, Martin JE, Broen J, Simeon CP, Beretta L, Gorlova OY, Vonk MC, Ortego-Centeno N, Espinosa G, Carreira P, Garcia De La Pena P, Oreiro N, Roman-Ivorra JA, Castillo MJ, Gonzalez-Gay MA, Saez-Comet L, Castellvi I, Schuerwegh AJ, Voskuyl AE, Hoffmann-Vold AM, Hesselstrand R, Nordin A, Lunardi C, Scorza R, Van Laar JM, Shiels PG, Herrick A, Worthington J, Fonseca C, Denton C, Denton C, et al. Confirmation of TNIP1 but not RHOB and PSORS1C1 as systemic sclerosis risk factors in a large independent replication study. Ann Rheum Dis 2013, 72:602-607. 10.1136/annrheumdis-2012-201888, 22896740.
18. Tontonoz P, Spiegelman BM. Fat and beyond: the diverse biology of PPARgamma. Annu Rev Biochem 2008, 77:289-312. 10.1146/annurev.biochem.77.061307.091829, 18518822.
19. Ghosh AK, Bhattacharyya S, Lakos G, Chen SJ, Mori Y, Varga J. Disruption of transforming growth factor beta signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator-activated receptor gamma. Arthritis Rheum 2004, 50:1305-1318. 10.1002/art.20104, 15077315.
20. Burgess HA, Daugherty LE, Thatcher TH, Lakatos HF, Ray DM, Redonnet M, Phipps RP, Sime PJ. PPARgamma agonists inhibit TGF-beta induced pulmonary myofibroblast differentiation and collagen production: implications for therapy of lung fibrosis. Am J Physiol Lung Cell Mol Physiol 2005, 288:L1146-L1153. 10.1152/ajplung.00383.2004, 15734787.
21. Kulkarni AA, Thatcher TH, Olsen KC, Maggirwar SB, Phipps RP, Sime PJ. PPAR-gamma ligands repress TGFbeta-induced myofibroblast differentiation by targeting the PI3K/Akt pathway: implications for therapy of fibrosis. PLoS One 2011, 6:e15909. 10.1371/journal.pone.0015909, 3017065, 21253589.
22. Wei J, Zhu H, Komura K, Lord G, Tomcik M, Wang W, Doniparthi S, Tamaki Z, Hinchcliff M, Distler JH, Varga J. A synthetic PPAR-gamma agonist triterpenoid ameliorates experimental fibrosis: PPAR-gamma-independent suppression of fibrotic responses. Ann Rheum Dis 2013, Epub ahead of print.
23. Wu M, Melichian DS, Chang E, Warner-Blankenship M, Ghosh AK, Varga J. Rosiglitazone abrogates bleomycin-induced scleroderma and blocks profibrotic responses through peroxisome proliferator-activated receptor-gamma. Am J Pathol 2009, 174:519-533. 10.2353/ajpath.2009.080574, 2630560, 19147827.
24. Wei J, Ghosh AK, Sargent JL, Komura K, Wu M, Huang QQ, Jain M, Whitfield ML, Feghali-Bostwick C, Varga J. PPARgamma downregulation by TGFss in fibroblast and impaired expression and function in systemic sclerosis: a novel mechanism for progressive fibrogenesis. PLoS One 2010, 5:e13778. 10.1371/journal.pone.0013778, 2970611, 21072170.
25. Glas J, Seiderer J, Markus C, Pfennig S, Wetzke M, Paschos E, Goke B, Ochsenkuhn T, Muller-Myhsok B, Diegelmann J, Roeske D, Brand S. Role of PPARG gene variants in inflammatory bowel disease. Inflamm Bowel Dis 2011, 17:1057-1058. 10.1002/ibd.21425, 20722066.
26. Zhang ZF, Yang N, Zhao G, Zhu L, Wang LX. Association between the Pro12Ala polymorphism of peroxisome proliferator-activated receptor gamma 2 and inflammatory bowel disease: a meta-analysis. PLoS One 2012, 7:e30551. 10.1371/journal.pone.0030551, 3261897, 22276212.
27. Butt C, Gladman D, Rahman P. PPAR-gamma gene polymorphisms and psoriatic arthritis. J Rheumatol 2006, 33:1631-1633.
28. Lyssenko V, Jonsson A, Almgren P, Pulizzi N, Isomaa B, Tuomi T, Berglund G, Altshuler D, Nilsson P, Groop L. Clinical risk factors, DNA variants, and the development of type 2 diabetes. N Engl J Med 2008, 359:2220-2232. 10.1056/NEJMoa0801869, 19020324.
29. Chu X, Pan CM, Zhao SX, Liang J, Gao GQ, Zhang XM, Yuan GY, Li CG, Xue LQ, Shen M, Liu W, Xie F, Yang SY, Wang HF, Shi JY, Sun WW, Du WH, Zuo CL, Shi JX, Liu BL, Guo CC, Zhan M, Gu ZH, Zhang XN, Sun F, Wang ZQ, Song ZY, Zou CY, Sun WH, Guo T, et al. A genome-wide association study identifies two new risk loci for Graves' disease. Nat Genet 2011, 43:897-901. 10.1038/ng.898, 21841780.
30. Szymanski K, Bednarczuk T, Krajewski P, Ploski R. The replication of the association of the rs6832151 within chromosomal band 4p14 with Graves' disease in a Polish Caucasian population. Tissue Antigens 2012, 79:380-383. 10.1111/j.1399-0039.2012.01854.x, 22489947.